Results
1 -
1 of
1
(Click
here to explore results)
- Discovery and optimisation of potent and highly subtype selective Nav1.8 inhibitors with reduced cardiovascular liabilities. Sharan K. Bagal, Mark I. Kemp, Peter J. Bungay, Tanya L. Hay, Yoshihisa Murata, C. Elizabeth Payne, Edward B. Stevens, Alan Brown, David C. Blakemore, Matthew S. Corbett, Duncan C. Miller, Kiyoyuki Omoto, Joseph S. Warmus
, Med. Chem. Commun.
, 2016
, 7
, 1925